Physician profile
Michael Lanuti
NPI 1992796817
$28,958.22
in general payments reported to CMS, 2019-2025
5 companies · $3,977 in 2025
The $3,977 reported for 2025 was more than what 79% of Thoracic Surgery (Cardiothoracic Vascular Surgery) providers received nationally (typical 2025 total: $796).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $1,575 · 2021: $4,028 · 2023: $4,259 · 2024: $15K · 2025: $3,977.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Education: $17K · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $3,120 · Travel and Lodging: $1,631 · Consulting Fee: $1,395 · Food and Beverage: $186.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Education | $17,023.36 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $3,120.00 |
| Travel and Lodging | $1,631.39 |
| Consulting Fee | $1,395.00 |
| Food and Beverage | $185.97 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $18,704.28 | 2023-2025 | Davinci Xi, Da Vinci Surgical System |
| Medtronic, INC. | $4,515.00 | 2023-2024 | Illumisite |
| Astrazeneca Pharmaceuticals LP | $4,027.50 | 2021 | |
| E.R. Squibb & Sons, L.L.C. | $1,575.00 | 2020 | |
| Baxter Healthcare | $136.44 | 2025 | Coseal |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michael Lanuti listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.